8 completed, 2 unknown, 1 recruiting, 1 terminated. 12 Phase 2, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 8, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 1 | 5 | Completed 3, Unknown 2 |
Follow Tobramycin: new trials by email Literature Review of Tobramycin trials Research Report on Tobramycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. Vancomycin + Tobramycin, Saline - Arthroplasty, Replacement, Hip, Osteoarthritis, Hip | Phase 2 | Recruiting | University Hospital, Linkoeping | 1100 | 2022-04-01 | 2026-07-10 |
| Abbreviated Protocol for Two-Stage Exchange VT-X7 Treatment System with Tobramycin Sulfate, Standard of Care, Two-stage exchange arthroplasty - Prosthetic Joint Infection | Phase 2 | Completed | Osteal Therapeutics, Inc. | 76 | 2021-11-01 | 2026-10-15 |
| DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis Tobramycin - Cystic Fibrosis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 10 | 2019-05-29 | 2021-10-01 |
| Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation vancomycin hydrochloride and tobramycin sulfate - Prosthetic Joint Infection | Phase 2 | Completed | Osteal Therapeutics, Inc. | 15 | 2018-10-26 | 2022-01-11 |
| Topical Antibiotics in Chronic Rhinosinusitis Mupirocin, Tobramycin, Levofloxacin - Chronic Rhinosinusitis (Diagnosis) | Phase 1 / Phase 2 | Completed | Mayo Clinic | 19 | 2018-09-26 | 2022-04-20 |
| Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study Tobramycin - Burns, Infection | Phase 1 / Phase 2 | Completed | Sandra Walker | 10 | 2015-03-01 | 2015-12-14 |
| Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis Tobramycin - Bronchiectasis | Phase 1 / Phase 2 | Completed | University Medical Center Groningen | 8 | 2013-10-01 | 2014-12-16 |
| Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis Tobramycin - Cystic Fibrosis | Phase 1 / Phase 2 | Unknown | Erempharma | 36 | 2011-04-01 | 2011-04-18 |
| Clinical Trials to Reduce the Risk of Antimicrobial Resistance IV meropenem, I.V. Meropenem, Parenteral aminoglycoside; tobramycin for injection USP OR gentamicin sulfate injection solution concentrate 5mg.kg IV q24h; amikacin sulfate injection USP 20 mg/kg IV q24h - Bacterial Pneumonia | Phase 2 | Terminated | University of Florida | 43 | 2010-09-01 | 2017-09-29 |
| Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization Tobramycin (Gernebcin®) - Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 2 | Completed | University of Jena | 9 | 2008-10-01 | 2014-12-04 |
| Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin - Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | Seattle Children's Hospital | 304 | 2004-09-01 | 2014-02-28 |
| A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis Tobramycin for Inhalation - Cystic Fibrosis | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 98 | 2000-02-01 | 2010-03-02 |
Cystic Fibrosis (5) · Pseudomonas Infections (2) · Bronchiectasis (1) · Burns (1) · Disease (1) · Infections (1) · Lung Diseases (1) · Osteoarthritis, Hip (1) · Pneumonia, Bacterial (1) · Pulmonary Disease, Chronic Obstructive (1)
Osteal Therapeutics, Inc. (2) · University Medical Center Groningen (2) · Erempharma (1) · Mayo Clinic (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Sandra Walker (1) · Seattle Children's Hospital (1) · University Hospital, Linkoeping (1) · University of Florida (1) · University of Jena (1)
United States (6) · France (2) · Germany (2) · Netherlands (2) · Canada (1) · Spain (1) · Sweden (1)
Bryan Springer, MD (2) · Bonnie W. Ramsey (1) · David Waltz, M.D. (1) · Gabriel Bellon (1) · Garret W Choby, MD (1) · George L Drusano, MD (1) · George Retsch-Bogart, M.D. (1) · George Retsch-Bogart, MD (1) · Gerard Koppelman, Prof. (1) · Huib Kerstjens, MD, PhD (1) · Isabelle Durieu, Pr (1) · Jeffrey Wagener, M.D. (1) · Jochen Mainz, M.D. (1) · Michael Konstan, M.D. (1)
PMID 21893650, PMID 24596456, PMID 25972024, PMID 26288390, PMID 29038277, PMID 38604274, PMID 42731828
M01RR000037 (1), R01DK057755 (1), U01HL080310 (1)